CYTH Message Board Post 8946594 | Cyclo Therapeutics Inc.
home / stock / cyth / cyth message board
jlatner
(investorshub)
Posted on: Oct/31/2022 21:41:57
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170335013
...but, but, but https://www.otcmarkets.com/filing/html?id=16164183&guid=FC
News, Short Squeeze, Breakout and More Instantly...
Cyclo Therapeutics Inc. Company Name:
CYTH Stock Symbol:
Market:
-
TransportNPC™ is the most comprehensive ongoing controlled pivotal study regarding patient size, global footprint, duration and clinical outcomes for the treatment of Niemann-Pick Disease Type C1 (NPC1) Topline data from the 48-week interim analysis of 104 enrolled patients is anti...
-
Ongoing progress toward last patient enrolled in pivotal Phase 3 study (“TransportNPC™”) evaluating Trappsol ® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1), expected Q2 2024 Topline data from 48-week interim analysis expected H1 2025...